Toronto Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 157,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "a0679a37-e841-468e-8499-22c3b3dae0c3",
"title": "TSX Today: What to Watch for in Stocks on Tuesday, May 24",
"description": "Top bank earnings could keep the banking sector volatile on the TSX this week.",
"keywords": "",
"snippet": "Canadian equities remained choppy in the last trading session before a long weekend. The S&P/TSX Composite Index rose slightly by 16 points Friday, helping the ...",
"url": "https://www.fool.ca/2022/05/24/tsx-today-what-to-watch-for-in-stocks-on-tuesday-may-24/",
"image_url": "https://www.fool.ca/wp-content/uploads/2021/09/TSX-Today.jpg",
"language": "en",
"published_at": "2022-05-24T12:00:00.000000Z",
"source": "fool.ca",
"relevance_score": null,
"entities": [
{
"symbol": "BBD-A.TO",
"name": "Bombardier Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 37.48427,
"sentiment_score": 0.872,
"highlights": [
{
"highlight": "<em>Bombardier</em>, Canopy Growth, and WSP Global were also among the worst-performing TSX stocks in the last session, as they slipped by more than 5% each.\n\nOn the positive side, shares of companies like Kinaxis, Dollarama, Open Text, and GFL Environmental were among the top-gaining Canadian stocks, as they rose by at least 3% each.",
"sentiment": 0.872,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABX.TO",
"name": "Barrick Gold Corporation",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Basic Materials",
"match_score": 42.670753,
"sentiment_score": 0.5809,
"highlights": [
{
"highlight": "Based on their daily trade volume, Great-West Lifeco, Crescent Point Energy, Suncor Energy, and <em>Barrick</em> <em>Gold</em> were the most active stocks on the exchange on Friday.\n\nTSX today\n\nWhile metals prices were continuing to strengthen early Tuesday morning, crude oil prices were trading on a mixed note.",
"sentiment": 0.5809,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BBD-B.TO",
"name": "Bombardier Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 37.48427,
"sentiment_score": 0.872,
"highlights": [
{
"highlight": "<em>Bombardier</em>, Canopy Growth, and WSP Global were also among the worst-performing TSX stocks in the last session, as they slipped by more than 5% each.\n\nOn the positive side, shares of companies like Kinaxis, Dollarama, Open Text, and GFL Environmental were among the top-gaining Canadian stocks, as they rose by at least 3% each.",
"sentiment": 0.872,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BBD-PD.TO",
"name": "Bombardier Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 37.483818,
"sentiment_score": 0.872,
"highlights": [
{
"highlight": "<em>Bombardier</em>, Canopy Growth, and WSP Global were also among the worst-performing TSX stocks in the last session, as they slipped by more than 5% each.\n\nOn the positive side, shares of companies like Kinaxis, Dollarama, Open Text, and GFL Environmental were among the top-gaining Canadian stocks, as they rose by at least 3% each.",
"sentiment": 0.872,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "WEED.TO",
"name": "Canopy Growth Corporation",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Healthcare",
"match_score": 40.657623,
"sentiment_score": 0.8074,
"highlights": [
{
"highlight": "Bombardier, <em>Canopy</em> <em>Growth</em>, and WSP Global were also among the worst-performing TSX stocks in the last session, as they slipped by more than 5% each.\n\nOn the positive side, shares of companies like Kinaxis, Dollarama, Open Text, and GFL Environmental were among the top-gaining Canadian stocks, as they rose by at least 3% each.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CPG.TO",
"name": "Crescent Point Energy Corp.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Energy",
"match_score": 43.930954,
"sentiment_score": 0.3947,
"highlights": [
{
"highlight": "Based on their daily trade volume, Great-West Lifeco, <em>Crescent</em> <em>Point</em> <em>Energy</em>, Suncor Energy, and Barrick Gold were the most active stocks on the exchange on Friday.\n\nTSX today\n\nWhile metals prices were continuing to strengthen early Tuesday morning, crude oil prices were trading on a mixed note.",
"sentiment": 0.3947,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "OTEX.TO",
"name": "Open Text Corporation",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Technology",
"match_score": 36.710117,
"sentiment_score": 0.8979,
"highlights": [
{
"highlight": "On the positive side, shares of companies like Kinaxis, Dollarama, <em>Open</em> <em>Text</em>, and GFL Environmental were among the top-gaining Canadian stocks, as they rose by at least 3% each.\n\nLightspeed Commerce (TSX:LSPD)(NYSE:LSPD) stock rose by nearly 7% last week to $29.51 per share after posting 9% gains in the previous week.",
"sentiment": 0.8979,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DOL.TO",
"name": "Dollarama Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 40.083683,
"sentiment_score": 0.8979,
"highlights": [
{
"highlight": "On the positive side, shares of companies like Kinaxis, <em>Dollarama</em>, Open Text, and GFL Environmental were among the top-gaining Canadian stocks, as they rose by at least 3% each.\n\nLightspeed Commerce (TSX:LSPD)(NYSE:LSPD) stock rose by nearly 7% last week to $29.51 per share after posting 9% gains in the previous week.",
"sentiment": 0.8979,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SU.TO",
"name": "Suncor Energy Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Energy",
"match_score": 42.3672,
"sentiment_score": 0.3947,
"highlights": [
{
"highlight": "Based on their daily trade volume, Great-West Lifeco, Crescent Point Energy, <em>Suncor</em> <em>Energy</em>, and Barrick Gold were the most active stocks on the exchange on Friday.\n\nTSX today\n\nWhile metals prices were continuing to strengthen early Tuesday morning, crude oil prices were trading on a mixed note.",
"sentiment": 0.3947,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GFL.TO",
"name": "GFL Environmental Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 44.2966,
"sentiment_score": 0.8979,
"highlights": [
{
"highlight": "On the positive side, shares of companies like Kinaxis, Dollarama, Open Text, and <em>GFL</em> <em>Environmental</em> were among the top-gaining Canadian stocks, as they rose by at least 3% each.\n\nLightspeed Commerce (TSX:LSPD)(NYSE:LSPD) stock rose by nearly 7% last week to $29.51 per share after posting 9% gains in the previous week.",
"sentiment": 0.8979,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GWO.TO",
"name": "Great-West Lifeco Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Financial Services",
"match_score": 47.3574,
"sentiment_score": 0.5809,
"highlights": [
{
"highlight": "Based on their daily trade volume, <em>Great</em>-<em>West</em> <em>Lifeco</em>, Crescent Point Energy, Suncor Energy, and Barrick Gold were the most active stocks on the exchange on Friday.\n\nTSX today\n\nWhile metals prices were continuing to strengthen early Tuesday morning, crude oil prices were trading on a mixed note.",
"sentiment": 0.5809,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "WSP.TO",
"name": "WSP Global Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 41.99681,
"sentiment_score": 0.872,
"highlights": [
{
"highlight": "Bombardier, Canopy Growth, and <em>WSP</em> <em>Global</em> were also among the worst-performing TSX stocks in the last session, as they slipped by more than 5% each.\n\nOn the positive side, shares of companies like Kinaxis, Dollarama, Open Text, and GFL Environmental were among the top-gaining Canadian stocks, as they rose by at least 3% each.",
"sentiment": 0.872,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SHOP.TO",
"name": "Shopify Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Technology",
"match_score": 49.65711,
"sentiment_score": 0.40515,
"highlights": [
{
"highlight": "Top TSX movers and active stocks\n\nShares of <em>Shopify</em> (<em>TSX:SHOP</em>)(NYSE:SHOP) fell by more than 7% on Friday to $466.30 per share, making it the worst-performing TSX Composite component for the session.",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "That explains why <em>Shopify</em> stock has fallen in six out of the last seven weeks.\n\nBombardier, Canopy Growth, and WSP Global were also among the worst-performing TSX stocks in the last session, as they slipped by more than 5% each.",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "KXS.TO",
"name": "Kinaxis Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Technology",
"match_score": 40.038322,
"sentiment_score": 0.8979,
"highlights": [
{
"highlight": "On the positive side, shares of companies like <em>Kinaxis</em>, Dollarama, Open Text, and GFL Environmental were among the top-gaining Canadian stocks, as they rose by at least 3% each.\n\nLightspeed Commerce (TSX:LSPD)(NYSE:LSPD) stock rose by nearly 7% last week to $29.51 per share after posting 9% gains in the previous week.",
"sentiment": 0.8979,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "3d734b8b-b444-4cf9-b46e-66113e7a276e",
"title": "The 4 Best Canadian Stocks Under $10 to Buy Today",
"description": "Canadian small-cap stocks are trading at all-time low valuations! Here are four top stocks below $10 per share that each have huge upside!",
"keywords": "",
"snippet": "Canadian small-cap stocks are trading at all-time low valuations! Here are four top stocks below $10 per share that each have huge upside!\n\nCanadian small-cap s...",
"url": "https://www.fool.ca/2022/05/24/the-4-best-canadian-stocks-under-10-to-buy-today/",
"image_url": "https://www.fool.ca/wp-content/uploads/2019/05/Canadian-Dollar.jpg",
"language": "en",
"published_at": "2022-05-24T12:00:00.000000Z",
"source": "fool.ca",
"relevance_score": null,
"entities": [
{
"symbol": "WCP.TO",
"name": "Whitecap Resources Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Energy",
"match_score": 34.509167,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "A solid dividend-paying energy stock\n\nAnother interesting resource stock with a renewable theme is <em>Whitecap</em> <em>Resources</em> (<em>TSX:WCP</em>). Yes, it is a mid-cap Canadian oil and gas producer. However, the company has carbon dioxide sequestration segment that makes its overall operations net carbon negative.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "51498ce1-9981-450e-a7d0-9b804195daef",
"title": "3 Under-$20 Dividend Stocks to Boost Your Passive Income",
"description": "Given their stable cash flows and high dividend yields, these three under-$20 Canadian stocks can boost your passive income.",
"keywords": "",
"snippet": "Given their stable cash flows and high dividend yields, these three under-$20 Canadian stocks can boost your passive income.\n\nWith inflation at a multi-decade h...",
"url": "https://www.fool.ca/2022/05/24/3-under-20-dividend-stocks-to-boost-your-passive-income/",
"image_url": "https://www.fool.ca/wp-content/uploads/2019/06/CanadianDollars.jpg",
"language": "en",
"published_at": "2022-05-24T11:59:32.000000Z",
"source": "fool.ca",
"relevance_score": null,
"entities": [
{
"symbol": "AQN.TO",
"name": "Algonquin Power & Utilities Corp.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Utilities",
"match_score": 41.210613,
"sentiment_score": 0.7834,
"highlights": [
{
"highlight": "<em>Algonquin</em> <em>Power</em> & <em>Utilities</em>\n\n<em>Algonquin</em> <em>Power</em> & <em>Utilities</em> (<em>TSX:AQN</em>)(NYSE:AQN) operates regulated utility assets and is also involved in renewable power production. Its solid underlying utility business, long-term power-purchase agreements, and strategical acquisitions generate stable and reliable cash flows.",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "Given its growth prospects, high dividend yield, and attractive NTM price-to-earnings multiple of 19.2, I believe <em>Algonquin</em> <em>Power</em> & <em>Utilities</em> would be an excellent addition to your portfolio.",
"sentiment": 0.886,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PZA.TO",
"name": "Pizza Pizza Royalty Corp.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 38.702984,
"sentiment_score": 0.802,
"highlights": [
{
"highlight": "<em>Pizza</em> <em>Pizza</em> <em>Royalty</em>\n\nSupported by its highly franchised business model, <em>Pizza</em> <em>Pizza</em> <em>Royalty</em> (<em>TSX:PZA</em>) generates stable cash flows irrespective of the economic cycle. Meanwhile, with the easing of restrictions, the company has reopened its non-traditional restaurants and dining spaces, which could boost its walk-in sales.",
"sentiment": 0.802,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "ad698fb1-d632-4fb6-9abd-923e59f2e41a",
"title": "Jefferies Financial Group Equities Analysts Lower Earnings Estimates for Primo Water Co. (NYSE:PRMW)",
"description": "Read Jefferies Financial Group Equities Analysts Lower Earnings Estimates for Primo Water Co. (NYSE:PRMW) at ETF Daily News",
"keywords": "Primo Water, NYSE:PRMW, PRMW, Utilitie, Earnings Estimates, Jefferies Financial Group Inc.",
"snippet": "Primo Water Co. (NYSE:PRMW – Get Rating) – Analysts at Jefferies Financial Group reduced their Q2 2022 earnings estimates for Primo Water in a research note...",
"url": "https://www.etfdailynews.com/2022/05/24/jefferies-financial-group-equities-analysts-lower-earnings-estimates-for-primo-water-co-nyseprmw/",
"image_url": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/primo-water-co-logo.png&w=240&h=240&zc=2",
"language": "en",
"published_at": "2022-05-24T11:58:55.000000Z",
"source": "etfdailynews.com",
"relevance_score": null,
"entities": [
{
"symbol": "PRMW.TO",
"name": "Primo Water Corporation",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 51.988827,
"sentiment_score": 0.284755,
"highlights": [
{
"highlight": "<em>Primo</em> <em>Water</em> Co. (NYSE:PRMW – Get Rating) – Analysts at Jefferies Financial Group reduced their Q2 2022 earnings estimates for <em>Primo</em> <em>Water</em> in a research note issued to investors on Sunday, May 22nd. Jefferies Financial Group analyst K.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Get <em>Primo</em> <em>Water</em> alerts:\n\nA number of other research analysts also recently weighed in on PRMW. Deutsche Bank Aktiengesellschaft reduced their target price on shares of <em>Primo</em> <em>Water</em> from $18.00 to $16.00 in a research report on Friday, May 13th.",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "TD Securities lowered their price objective on shares of <em>Primo</em> <em>Water</em> from $23.00 to $21.00 and set a “buy” rating on the stock in a research report on Friday, February 25th. Citigroup reduced their target price on shares of <em>Primo</em> <em>Water</em> from $21.00 to $18.00 and set a “buy” rating on the stock in a report on Friday, February 25th.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Finally, Zacks Investment Research raised shares of <em>Primo</em> <em>Water</em> from a “strong sell” rating to a “hold” rating and set a $16.00 target price on the stock in a report on Saturday, May 14th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Primo</em> <em>Water</em> has a twelve month low of $13.26 and a twelve month high of $20.12. The firm has a fifty day simple moving average of $14.34 and a 200 day simple moving average of $15.91. The company has a market capitalization of $2.24 billion, a PE ratio of -697.50 and a beta of 1.33.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Primo</em> <em>Water</em> (NYSE:PRMW – Get Rating) last posted its quarterly earnings results on Thursday, May 12th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.02. The business had revenue of $526.10 million for the quarter, compared to analyst estimates of $516.19 million.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Ancora Advisors LLC bought a new position in <em>Primo</em> <em>Water</em> during the 1st quarter worth about $36,000. Connable Office Inc. acquired a new position in <em>Primo</em> <em>Water</em> during the first quarter valued at approximately $148,000. Bridgefront Capital LLC acquired a new position in <em>Primo</em> <em>Water</em> during the first quarter valued at approximately $177,000.",
"sentiment": 0.7717,
"highlighted_in": "main_text"
},
{
"highlight": "Tudor Investment Corp Et Al bought a new stake in shares of <em>Primo</em> <em>Water</em> during the third quarter worth $188,000. Finally, Brown Advisory Inc. bought a new stake in shares of <em>Primo</em> <em>Water</em> during the fourth quarter worth $199,000. Hedge funds and other institutional investors own 93.36% of the company’s stock.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Primo</em> <em>Water</em> (Get Rating)\n\n<em>Primo</em> <em>Water</em> <em>Corporation</em> provides water direct to consumers and water filtration services in North America and Europe.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Receive News & Ratings for <em>Primo</em> <em>Water</em> Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for <em>Primo</em> <em>Water</em> and related companies with MarketBeat.com's FREE daily email newsletter.",
"sentiment": 0.6166,
"highlighted_in": "main_text"
},
{
"highlight": "Jefferies Financial Group Equities Analysts Lower Earnings Estimates for <em>Primo</em> <em>Water</em> Co. (NYSE:PRMW)",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "9a4deaad-3eed-4292-a530-67d7bdf56806",
"title": "TheStreet Lowers Equinox Gold (NYSEAMERICAN:EQX) to C+",
"description": "Read TheStreet Lowers Equinox Gold (NYSEAMERICAN:EQX) to C+ at ETF Daily News",
"keywords": "Equinox Gold, NYSEAMERICAN:EQX, EQX, Basic Material, Downgrade, TheStreet",
"snippet": "Equinox Gold (NYSEAMERICAN:EQX – Get Rating) was downgraded by investment analysts at TheStreet from a “b-” rating to a “c+” rating in a report issued...",
"url": "https://www.etfdailynews.com/2022/05/24/thestreet-lowers-equinox-gold-nyseamericaneqx-to-c/",
"image_url": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/equinox-gold-corp-logo.png&w=240&h=240&zc=2",
"language": "en",
"published_at": "2022-05-24T11:58:54.000000Z",
"source": "etfdailynews.com",
"relevance_score": null,
"entities": [
{
"symbol": "EQX.TO",
"name": "Equinox Gold Corp.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Basic Materials",
"match_score": 80.896225,
"sentiment_score": 0.200527,
"highlights": [
{
"highlight": "<em>Equinox</em> <em>Gold</em> (NYSEAMERICAN:EQX – Get Rating) was downgraded by investment analysts at TheStreet from a “b-” rating to a “c+” rating in a report issued on Friday, TheStreetRatingsTable reports.\n\nEQX has been the topic of several other reports.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "BMO Capital Markets dropped their target price on <em>Equinox</em> <em>Gold</em> from C$14.50 to C$14.00 in a report on Tuesday, May 17th. Canaccord Genuity Group dropped their target price on <em>Equinox</em> <em>Gold</em> from C$10.50 to C$10.00 and set a “buy” rating on the stock in a report on Wednesday, January 26th.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "National Bank Financial raised their target price on <em>Equinox</em> <em>Gold</em> from C$13.00 to C$14.00 in a report on Wednesday, April 20th. Scotiabank lowered <em>Equinox</em> <em>Gold</em> from an “outperform” rating to a “sector perform” rating in a report on Thursday, May 5th.",
"sentiment": -0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Finally, TD Securities dropped their target price on <em>Equinox</em> <em>Gold</em> from C$15.50 to C$12.50 in a report on Thursday, May 5th. Five investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Get <em>Equinox</em> <em>Gold</em> alerts:\n\nShares of EQX stock opened at $5.76 on Friday. <em>Equinox</em> <em>Gold</em> has a 1-year low of $5.25 and a 1-year high of $9.55. The stock has a market cap of $1.75 billion, a P/E ratio of 4.84 and a beta of 1.11. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.20 and a current ratio of 2.84.",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Equinox</em> <em>Gold</em> ( NYSEAMERICAN:EQX Get Rating ) last issued its quarterly earnings data on Thursday, February 24th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.04. <em>Equinox</em> <em>Gold</em> had a return on equity of 2.51% and a net margin of 38.26%.",
"sentiment": -0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "On average, equities analysts anticipate that <em>Equinox</em> <em>Gold</em> will post 0.3 earnings per share for the current fiscal year.\n\nA number of institutional investors have recently made changes to their positions in the stock. Wells Fargo & Company MN lifted its position in <em>Equinox</em> <em>Gold</em> by 55.2% during the fourth quarter.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "Toronto Dominion Bank raised its position in <em>Equinox</em> <em>Gold</em> by 0.7% in the first quarter. Toronto Dominion Bank now owns 263,779 shares of the company’s stock valued at $2,181,000 after purchasing an additional 1,858 shares during the period. PNC Financial Services Group Inc. raised its position in <em>Equinox</em> <em>Gold</em> by 5.8% in the first quarter.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Equinox</em> <em>Gold</em> (Get Rating)\n\n<em>Equinox</em> <em>Gold</em> <em>Corp</em>. engages in the operation, acquisition, exploration, and development of mineral properties. The company primarily explores for gold and silver deposits.",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Receive News & Ratings for <em>Equinox</em> <em>Gold</em> Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for <em>Equinox</em> <em>Gold</em> and related companies with MarketBeat.com's FREE daily email newsletter.",
"sentiment": 0.6166,
"highlighted_in": "main_text"
},
{
"highlight": "TheStreet Lowers <em>Equinox</em> <em>Gold</em> (NYSEAMERICAN:EQX) to C+",
"sentiment": -0.128,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "1ac77816-6df7-427e-a31b-8fe8df5371d7",
"title": "Research Analysts’ Weekly Ratings Updates for EverQuote (EVER)",
"description": "Read Research Analysts’ Weekly Ratings Updates for EverQuote (EVER) at ETF Daily News",
"keywords": "EverQuote Inc, NASDAQ:EVER, EVER",
"snippet": "EverQuote (NASDAQ: EVER) recently received a number of ratings updates from brokerages and research firms:\n\n5/3/2022 – EverQuote was downgraded by analysts at...",
"url": "https://www.etfdailynews.com/2022/05/24/research-analysts-weekly-ratings-updates-for-everquote-ever/",
"image_url": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/everquote-inc-logo.png&w=240&h=240&zc=2",
"language": "en",
"published_at": "2022-05-24T11:46:47.000000Z",
"source": "etfdailynews.com",
"relevance_score": null,
"entities": [
{
"symbol": "CF.TO",
"name": "Canaccord Genuity Group Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Financial Services",
"match_score": 34.866997,
"sentiment_score": -0.064,
"highlights": [
{
"highlight": "from brokerages and research firms:\n\n5/3/2022 – EverQuote was downgraded by analysts at William Blair from an “outperform” rating to a “market perform” rating.\n\n5/3/2022 – EverQuote was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating.\n\n5/3/2022 – EverQuote had its price target lowered by analysts at <em>Canaccord</em>",
"sentiment": -0.128,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Genuity</em> <em>Group</em> <em>Inc</em>. from $25.00 to $22.00.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "c2e763d3-a7b3-49df-b69e-aa2006137484",
"title": "Weekly Investment Analysts’ Ratings Updates for Xebec Adsorption (XBC)",
"description": "Read Weekly Investment Analysts’ Ratings Updates for Xebec Adsorption (XBC) at ETF Daily News",
"keywords": "Xebec Adsorption Inc, TSE:XBC, XBC",
"snippet": "Several brokerages have updated their recommendations and price targets on shares of Xebec Adsorption (TSE: XBC) in the last few weeks:\n\n5/13/2022 – Xebec Ads...",
"url": "https://www.etfdailynews.com/2022/05/24/weekly-investment-analysts-ratings-updates-for-xebec-adsorption-xbc/",
"image_url": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/generic-stocks.jpg&w=240&h=240&zc=2",
"language": "en",
"published_at": "2022-05-24T06:18:46.000000Z",
"source": "etfdailynews.com",
"relevance_score": null,
"entities": [
{
"symbol": "XEBEF",
"name": "Xebec Adsorption Inc.",
"exchange": "OTC",
"exchange_long": "Over-the-counter Markets",
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 129.84981,
"sentiment_score": 0.047164,
"highlights": [
{
"highlight": "Several brokerages have updated their recommendations and price targets on shares of <em>Xebec</em> <em>Adsorption</em> (TSE: XBC) in the last few weeks:\n\n5/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target lowered by analysts at National Bankshares, Inc. from C$3.75 to C$2.00.",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "They now have a “sector perform” rating on the stock.\n\n5/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target lowered by analysts at Eight Capital from C$2.75 to C$2.00. They now have a “neutral” rating on the stock.\n\n5/13/2022 – <em>Xebec</em> <em>Adsorption</em> was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating.",
"sentiment": -0.128,
"highlighted_in": "main_text"
},
{
"highlight": "They now have a C$1.75 price target on the stock, down previously from C$3.25.\n\n5/12/2022 – <em>Xebec</em> <em>Adsorption</em> was downgraded by analysts at National Bank Financial from an “outperform spec overweight” rating to a “sector perform overweight” rating.\n\n4/14/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target raised by analysts at Raymond James from C$3.00 to C",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "They now have an “outperform” rating on the stock.\n\n4/14/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target raised by analysts at Canaccord Genuity Group Inc. from C$2.25 to C$2.50.\n\n4/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target raised by analysts at National Bankshares, Inc. from C$3.25 to C$3.75.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "They now have an “outperform” rating on the stock.\n\n4/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its “neutral” rating reaffirmed by analysts at Eight Capital. They now have a C$2.75 price target on the stock, up previously from C$2.40.\n\n4/4/2022 – <em>Xebec</em> <em>Adsorption</em> is now covered by analysts at Scotiabank.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "They now have a C$3.25 price target on the stock, down previously from C$4.00.\n\n3/30/2022 – <em>Xebec</em> <em>Adsorption</em> was upgraded by analysts at National Bank Financial from a “sector perform spec overwgt” rating to an “outperform spec overweight” rating.\n\n3/30/2022 – <em>Xebec</em> <em>Adsorption</em> was upgraded by analysts at Raymond James from a “market perform” rating",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xebec</em> <em>Adsorption</em> <em>Inc</em>. has a 12-month low of C$0.76 and a 12-month high of C$5.38. The company has a current ratio of 1.79, a quick ratio of 0.93 and a debt-to-equity ratio of 28.57. The company has a market cap of C$139.25 million and a PE ratio of -4.37.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Get <em>Xebec</em> <em>Adsorption</em> <em>Inc</em> alerts:\n\n<em>Xebec</em> <em>Adsorption</em> (TSE:XBC – Get Rating) last issued its quarterly earnings data on Thursday, May 12th. The company reported C($0.12) EPS for the quarter, missing analysts’ consensus estimates of C($0.04) by C($0.08).",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Equities analysts forecast that <em>Xebec</em> <em>Adsorption</em> <em>Inc</em>. will post -0.05 EPS for the current fiscal year.\n\n<em>Xebec</em> <em>Adsorption</em> <em>Inc</em> designs, manufactures, and sells purification, separation, dehydration, and filtration equipment for gases and compressed air in Canada, the United States, China, Korea, Italy, France, and internationally.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Receive News & Ratings for <em>Xebec</em> <em>Adsorption</em> <em>Inc</em> Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for <em>Xebec</em> <em>Adsorption</em> <em>Inc</em> and related companies with MarketBeat.com's FREE daily email newsletter.",
"sentiment": 0.6166,
"highlighted_in": "main_text"
},
{
"highlight": "Weekly Investment Analysts’ Ratings Updates for <em>Xebec</em> <em>Adsorption</em> (XBC)",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "CCORF",
"name": "Canaccord Genuity Group Inc.",
"exchange": "OTC",
"exchange_long": "Over-the-counter Markets",
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 33.27848,
"sentiment_score": 0,
"highlights": [
{
"highlight": "They now have an “outperform” rating on the stock.\n\n4/14/2022 – Xebec Adsorption had its price target raised by analysts at <em>Canaccord</em> <em>Genuity</em> <em>Group</em> <em>Inc</em>. from C$2.25 to C$2.50.\n\n4/13/2022 – Xebec Adsorption had its price target raised by analysts at National Bankshares, Inc. from C$3.25 to C$3.75.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "XBC.V",
"name": "Xebec Adsorption Inc.",
"exchange": "TSXV",
"exchange_long": "TSX Venture Exchange",
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 129.77937,
"sentiment_score": 0.047164,
"highlights": [
{
"highlight": "Several brokerages have updated their recommendations and price targets on shares of <em>Xebec</em> <em>Adsorption</em> (TSE: XBC) in the last few weeks:\n\n5/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target lowered by analysts at National Bankshares, Inc. from C$3.75 to C$2.00.",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "They now have a “sector perform” rating on the stock.\n\n5/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target lowered by analysts at Eight Capital from C$2.75 to C$2.00. They now have a “neutral” rating on the stock.\n\n5/13/2022 – <em>Xebec</em> <em>Adsorption</em> was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating.",
"sentiment": -0.128,
"highlighted_in": "main_text"
},
{
"highlight": "They now have a C$1.75 price target on the stock, down previously from C$3.25.\n\n5/12/2022 – <em>Xebec</em> <em>Adsorption</em> was downgraded by analysts at National Bank Financial from an “outperform spec overweight” rating to a “sector perform overweight” rating.\n\n4/14/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target raised by analysts at Raymond James from C$3.00 to C",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "They now have an “outperform” rating on the stock.\n\n4/14/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target raised by analysts at Canaccord Genuity Group Inc. from C$2.25 to C$2.50.\n\n4/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target raised by analysts at National Bankshares, Inc. from C$3.25 to C$3.75.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "They now have an “outperform” rating on the stock.\n\n4/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its “neutral” rating reaffirmed by analysts at Eight Capital. They now have a C$2.75 price target on the stock, up previously from C$2.40.\n\n4/4/2022 – <em>Xebec</em> <em>Adsorption</em> is now covered by analysts at Scotiabank.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "They now have a C$3.25 price target on the stock, down previously from C$4.00.\n\n3/30/2022 – <em>Xebec</em> <em>Adsorption</em> was upgraded by analysts at National Bank Financial from a “sector perform spec overwgt” rating to an “outperform spec overweight” rating.\n\n3/30/2022 – <em>Xebec</em> <em>Adsorption</em> was upgraded by analysts at Raymond James from a “market perform” rating",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xebec</em> <em>Adsorption</em> <em>Inc</em>. has a 12-month low of C$0.76 and a 12-month high of C$5.38. The company has a current ratio of 1.79, a quick ratio of 0.93 and a debt-to-equity ratio of 28.57. The company has a market cap of C$139.25 million and a PE ratio of -4.37.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Get <em>Xebec</em> <em>Adsorption</em> <em>Inc</em> alerts:\n\n<em>Xebec</em> <em>Adsorption</em> (TSE:XBC – Get Rating) last issued its quarterly earnings data on Thursday, May 12th. The company reported C($0.12) EPS for the quarter, missing analysts’ consensus estimates of C($0.04) by C($0.08).",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Equities analysts forecast that <em>Xebec</em> <em>Adsorption</em> <em>Inc</em>. will post -0.05 EPS for the current fiscal year.\n\n<em>Xebec</em> <em>Adsorption</em> <em>Inc</em> designs, manufactures, and sells purification, separation, dehydration, and filtration equipment for gases and compressed air in Canada, the United States, China, Korea, Italy, France, and internationally.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Receive News & Ratings for <em>Xebec</em> <em>Adsorption</em> <em>Inc</em> Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for <em>Xebec</em> <em>Adsorption</em> <em>Inc</em> and related companies with MarketBeat.com's FREE daily email newsletter.",
"sentiment": 0.6166,
"highlighted_in": "main_text"
},
{
"highlight": "Weekly Investment Analysts’ Ratings Updates for <em>Xebec</em> <em>Adsorption</em> (XBC)",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "NKSH",
"name": "National Bankshares, Inc.",
"exchange": "NASDAQ",
"exchange_long": "NASDAQ Stock Exchange",
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 41.022095,
"sentiment_score": 0.0593,
"highlights": [
{
"highlight": "Several brokerages have updated their recommendations and price targets on shares of Xebec Adsorption (TSE: XBC) in the last few weeks:\n\n5/13/2022 – Xebec Adsorption had its price target lowered by analysts at <em>National</em> <em>Bankshares</em>, <em>Inc</em>. from C$3.75 to C$2.00.",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "They now have an “outperform” rating on the stock.\n\n4/14/2022 – Xebec Adsorption had its price target raised by analysts at Canaccord Genuity Group Inc. from C$2.25 to C$2.50.\n\n4/13/2022 – Xebec Adsorption had its price target raised by analysts at <em>National</em> <em>Bankshares</em>, <em>Inc</em>. from C$3.25 to C$3.75.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "They now have a C$2.75 price target on the stock, down previously from C$3.00.\n\n3/31/2022 – Xebec Adsorption was upgraded by analysts at <em>National</em> <em>Bankshares</em>, <em>Inc</em>. from a “sector perform” rating to a “buy” rating.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CF.TO",
"name": "Canaccord Genuity Group Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Financial Services",
"match_score": 33.280064,
"sentiment_score": 0,
"highlights": [
{
"highlight": "They now have an “outperform” rating on the stock.\n\n4/14/2022 – Xebec Adsorption had its price target raised by analysts at <em>Canaccord</em> <em>Genuity</em> <em>Group</em> <em>Inc</em>. from C$2.25 to C$2.50.\n\n4/13/2022 – Xebec Adsorption had its price target raised by analysts at National Bankshares, Inc. from C$3.25 to C$3.75.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "XBC.TO",
"name": "Xebec Adsorption Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 129.81662,
"sentiment_score": 0.047164,
"highlights": [
{
"highlight": "Several brokerages have updated their recommendations and price targets on shares of <em>Xebec</em> <em>Adsorption</em> (TSE: XBC) in the last few weeks:\n\n5/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target lowered by analysts at National Bankshares, Inc. from C$3.75 to C$2.00.",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "They now have a “sector perform” rating on the stock.\n\n5/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target lowered by analysts at Eight Capital from C$2.75 to C$2.00. They now have a “neutral” rating on the stock.\n\n5/13/2022 – <em>Xebec</em> <em>Adsorption</em> was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating.",
"sentiment": -0.128,
"highlighted_in": "main_text"
},
{
"highlight": "They now have a C$1.75 price target on the stock, down previously from C$3.25.\n\n5/12/2022 – <em>Xebec</em> <em>Adsorption</em> was downgraded by analysts at National Bank Financial from an “outperform spec overweight” rating to a “sector perform overweight” rating.\n\n4/14/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target raised by analysts at Raymond James from C$3.00 to C",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "They now have an “outperform” rating on the stock.\n\n4/14/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target raised by analysts at Canaccord Genuity Group Inc. from C$2.25 to C$2.50.\n\n4/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its price target raised by analysts at National Bankshares, Inc. from C$3.25 to C$3.75.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "They now have an “outperform” rating on the stock.\n\n4/13/2022 – <em>Xebec</em> <em>Adsorption</em> had its “neutral” rating reaffirmed by analysts at Eight Capital. They now have a C$2.75 price target on the stock, up previously from C$2.40.\n\n4/4/2022 – <em>Xebec</em> <em>Adsorption</em> is now covered by analysts at Scotiabank.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "They now have a C$3.25 price target on the stock, down previously from C$4.00.\n\n3/30/2022 – <em>Xebec</em> <em>Adsorption</em> was upgraded by analysts at National Bank Financial from a “sector perform spec overwgt” rating to an “outperform spec overweight” rating.\n\n3/30/2022 – <em>Xebec</em> <em>Adsorption</em> was upgraded by analysts at Raymond James from a “market perform” rating",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xebec</em> <em>Adsorption</em> <em>Inc</em>. has a 12-month low of C$0.76 and a 12-month high of C$5.38. The company has a current ratio of 1.79, a quick ratio of 0.93 and a debt-to-equity ratio of 28.57. The company has a market cap of C$139.25 million and a PE ratio of -4.37.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Get <em>Xebec</em> <em>Adsorption</em> <em>Inc</em> alerts:\n\n<em>Xebec</em> <em>Adsorption</em> (TSE:XBC – Get Rating) last issued its quarterly earnings data on Thursday, May 12th. The company reported C($0.12) EPS for the quarter, missing analysts’ consensus estimates of C($0.04) by C($0.08).",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Equities analysts forecast that <em>Xebec</em> <em>Adsorption</em> <em>Inc</em>. will post -0.05 EPS for the current fiscal year.\n\n<em>Xebec</em> <em>Adsorption</em> <em>Inc</em> designs, manufactures, and sells purification, separation, dehydration, and filtration equipment for gases and compressed air in Canada, the United States, China, Korea, Italy, France, and internationally.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Receive News & Ratings for <em>Xebec</em> <em>Adsorption</em> <em>Inc</em> Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for <em>Xebec</em> <em>Adsorption</em> <em>Inc</em> and related companies with MarketBeat.com's FREE daily email newsletter.",
"sentiment": 0.6166,
"highlighted_in": "main_text"
},
{
"highlight": "Weekly Investment Analysts’ Ratings Updates for <em>Xebec</em> <em>Adsorption</em> (XBC)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "c5dc1adb-6d11-43e0-b40f-bfa1fd96a742",
"title": "Knight Therapeutics celebra acordo exclusivo de licenciamento e fornecimento com a Rigel Pharmaceuticals para comercializar o fármaco fostamatinib na América Latina",
"description": "/PRNewswire/ -- a Knight Therapeutics Inc. (TSX: GUD), empresa farmacêutica especializada pan-americana (ex-USA), anunciou hoje que firmou acordo exclusivo de...",
"keywords": "Knight Therapeutics Inc.",
"snippet": "MONTREAL, 24 de maio de 2022 /PRNewswire/ -- a Knight Therapeutics Inc. (TSX: GUD), empresa farmacêutica especializada pan-americana (ex-USA), anunciou hoje qu...",
"url": "https://www.prnewswire.com:443/news-releases/knight-therapeutics-celebra-acordo-exclusivo-de-licenciamento-e-fornecimento-com-a-rigel-pharmaceuticals-para-comercializar-o-farmaco-fostamatinib-na-america-latina-892384302.html",
"image_url": "https://mma.prnewswire.com/media/1824757/Knight_Therapeutics_Knight_Therapeutics_celebra_acordo_exclusivo.jpg?p=facebook",
"language": "en",
"published_at": "2022-05-24T11:45:00.000000Z",
"source": "prnewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "GUD.TO",
"name": "Knight Therapeutics Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Healthcare",
"match_score": 87.47632,
"sentiment_score": -0.12045,
"highlights": [
{
"highlight": "MONTREAL, 24 de maio de 2022 /PRNewswire/ -- a <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>TSX</em>: <em>GUD</em>), empresa farmacêutica especializada pan-americana (ex-USA), anunciou hoje que firmou acordo exclusivo de licenciamento e fornecimento com a Rigel Pharmaceuticals que concede à Knight o direito de comercializar o fármaco fostamatinib, um inibidor da tirosina-quinase (SYK) do baço administrado por via oral, na América Latina.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Sobre a <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.\n\nA <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>., com escritório central em Montreal, Canadá, é uma empresa farmacêutica especializada focada em adquirir ou licenciar e comercializar produtos farmacêuticos para o Canadá e América Latina.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. negocia suas ações na TSX com o código GUD. Para obter mais informações sobre a <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>., visite o site da empresa em www.gud-knight.com ou www.sedar.com.\n\nDeclarações relativas ao futuro\n\nEste documento contém declarações relativas ao futuro em relação a <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. e suas subsidiárias.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. considera as suposições nas quais essas declarações relativas ao futuro se baseiam como razoáveis no momento em que foram preparadas, mas adverte o leitor de que essas suposições sobre eventos futuros, muitos dos quais estão além do controle da <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. e de suas subsidiárias, podem acabar sendo incorretas.",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Fatores e riscos que podem fazer com que os resultados reais difiram materialmente das expectativas atuais são discutidos no Relatório Anual da <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. e no Formulário de Informações Anuais da <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. para o ano encerrado em 31 de dezembro de 2021, arquivado em www.sedar.com.",
"sentiment": -0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "A <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. nega qualquer intenção ou obrigação de atualizar ou revisar quaisquer declarações relativas ao futuro devido a novas informações ou eventos futuros, exceto conforme seja exigido por lei.\n\nConsulte www.TAVALISSE.com para a informação de prescrição completa.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Contato do investidor para a <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.:\n\n<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.\n\nReferências:\n\n1. Clinicaltrials.gov: NCT03764618\n\n2. Clinicaltrials.gov: NCT04629703\n\n3. Clinicaltrials.gov: NCT04924660\n\n4. Berlim DA, Gulick RM, e Martinez FJ. Severe Covid-19. N Engl J Med 2020. DOI: https://doi.org/10.1056/NEJMcp2009575\n\n5. Becker RC.",
"sentiment": -0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "DOI: https://doi.org/10.1101/2021.03.26.437014\n\nLogo - https://mma.prnewswire.com/media/1824757/Knight_Therapeutics_Knight_Therapeutics_celebra_acordo_exclusivo.jpg\n\nFONTE <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.\n\nSOURCE <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> celebra acordo exclusivo de licenciamento e fornecimento com a Rigel Pharmaceuticals para comercializar o fármaco fostamatinib na América Latina",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "b2b35daa-5114-47f8-b828-bd22b7eedb8f",
"title": "Knight Therapeutics celebra contratos de licencia exclusiva y suministro con Rigel Pharmaceuticals para comercializar fostamatinib en América Latina",
"description": "/PRNewswire/ -- Knight Therapeutics Inc. (TSX: GUD), una empresa farmacéutica especializada panamericana (ex- Estados Unidos) anunció hoy su firma en un...",
"keywords": "Knight Therapeutics Inc.",
"snippet": "MONTREAL, 24 de mayo de 2022 /PRNewswire/ -- Knight Therapeutics Inc. (TSX: GUD), una empresa farmacéutica especializada panamericana (ex- Estados Unidos) anun...",
"url": "https://www.prnewswire.com:443/news-releases/knight-therapeutics-celebra-contratos-de-licencia-exclusiva-y-suministro-con-rigel-pharmaceuticals-para-comercializar-fostamatinib-en-america-latina-893826931.html",
"image_url": "https://mma.prnewswire.com/media/1824758/Knight_Therapeutics_Knight_Therapeutics_celebra_contratos_de_lic.jpg?p=facebook",
"language": "en",
"published_at": "2022-05-24T11:45:00.000000Z",
"source": "prnewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "GUD.TO",
"name": "Knight Therapeutics Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Healthcare",
"match_score": 89.58661,
"sentiment_score": 0,
"highlights": [
{
"highlight": "MONTREAL, 24 de mayo de 2022 /PRNewswire/ -- <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>TSX</em>: <em>GUD</em>), una empresa farmacéutica especializada panamericana (ex- Estados Unidos) anunció hoy su firma en un contrato de licencia exclusiva y suministro con Rigel Pharmaceuticals que otorgan a Knight los derechos para comercializar fostamatinib, un inhibidor oral de la tirosina quinasa del bazo (SYK) en América Latina.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Acerca de <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.\n\n<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>., con sede en Montreal, Canadá, es una empresa farmacéutica especializada que se centra en adquirir o otorgar licencias y comercializar productos farmacéuticos para Canadá y América Latina.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Las acciones de <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. cotizan en TSX con el símbolo GUD. Para obtener más información acerca de <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>., visite el sitio web de la empresa en www.gud-knight.com o www.sedar.com.\n\nDeclaraciones prospectivas de <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Este documento contiene declaraciones prospectivas de <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. y sus sucursales. Estas declaraciones, por su naturaleza, implican necesariamente riesgos e incertidumbres que podrían causar que los resultados reales difieran sustancialmente de los contemplados en ellas.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. considera que las suposiciones en las que se basan estas declaraciones prospectivas eran razonables en el momento en que se prepararon, pero advierte al lector que las mismas con respecto a eventos futuros, muchos de los cuales están fuera del control de <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. y sus sucursales, pueden resultar ser incorrectas",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Los factores y riesgos que podrían ocasionar que los resultados reales difieran significativamente de las expectativas actuales se analizan en el Informe anual de <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. y en el Formulario de información anual de <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. para el año finalizado el 31 de diciembre de 2021, tal como se presentó en www.sedar.com.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. renuncia a cualquier intención u obligación de actualizar o revisar cualquier declaración prospectiva, ya sea como resultado de nueva información o eventos futuros, excepto según lo exija la ley.\n\nPara obtener información de prescripción completa, visite www.tavalisse.com.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Contacto para inversores de <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.:\n\n<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "DOI: https://doi.org/10.1101/2021.03.26.437014\n\nLogo - https://mma.prnewswire.com/media/1824758/Knight_Therapeutics_Knight_Therapeutics_celebra_contratos_de_lic.jpg\n\nFUENTE <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.\n\nSOURCE <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> celebra contratos de licencia exclusiva y suministro con Rigel Pharmaceuticals para comercializar fostamatinib en América Latina",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "2fccb3a3-ee2d-4ddb-99d2-9812fe9cf2f4",
"title": "Knight Therapeutics Enters into Exclusive License and Supply Agreements with Rigel Pharmaceuticals to Commercialize Fostamatinib in Latin America",
"description": "MONTREAL, May 24, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD), a pan-American (ex-USA) specialty pharmaceutical company, today announced...",
"keywords": "Toronto Stock Exchange:GUD, Knight Therapeutics",
"snippet": "English French\n\nMONTREAL, May 24, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD), a pan-American (ex-USA) specialty pharmaceutical company, today ...",
"url": "https://www.globenewswire.com/news-release/2022/05/24/2449210/0/en/Knight-Therapeutics-Enters-into-Exclusive-License-and-Supply-Agreements-with-Rigel-Pharmaceuticals-to-Commercialize-Fostamatinib-in-Latin-America.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/02c4072d-9fea-4ff1-bd39-1b5405586ad1?size=1",
"language": "en",
"published_at": "2022-05-24T11:30:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "RIGL",
"name": "Rigel Pharmaceuticals, Inc.",
"exchange": "NASDAQ",
"exchange_long": "NASDAQ Stock Exchange",
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 69.223404,
"sentiment_score": 0.313067,
"highlights": [
{
"highlight": "(TSX: GUD), a pan-American (ex-USA) specialty pharmaceutical company, today announced that it has entered into exclusive license and supply agreements with <em>Rigel</em> <em>Pharmaceuticals</em> granting Knight the rights to commercialize fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, in Latin America.",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "TAVALISSE and TAVLESSE are registered trademarks of <em>Rigel</em> <em>Pharmaceuticals</em>, <em>Inc</em>.\n\nInvestor Contact for Knight Therapeutics Inc.:\n\nKnight Therapeutics Inc.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Knight Therapeutics Enters into Exclusive License and Supply Agreements with <em>Rigel</em> <em>Pharmaceuticals</em> to Commercialize Fostamatinib in Latin America",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
},
{
"symbol": "KHTRF",
"name": "Knight Therapeutics Inc.",
"exchange": "OTC",
"exchange_long": "Over-the-counter Markets",
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 73.9124,
"sentiment_score": 0.183288,
"highlights": [
{
"highlight": "English French\n\nMONTREAL, May 24, 2022 (GLOBE NEWSWIRE) -- <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About Knight\n\n<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.'s shares trade on TSX under the symbol GUD. For more information about <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>., please visit the company's web site at www.gud-knight.com or www.sedar.com.\n\nForward-Looking Statements for Knight\n\nThis document contains forward-looking statements for <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. and its subsidiaries.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared but cautions the reader that these assumptions regarding future events, many of which are beyond the control of <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. and its subsidiaries, may ultimately prove to be incorrect.",
"sentiment": 0.1154,
"highlighted_in": "main_text"
},
{
"highlight": "Factors and risks, which could cause actual results to differ materially from current expectations are discussed in <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.'s Annual Report and in <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.'s Annual Information Form for the year ended December 31, 2021, as filed on www.sedar.com.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information or future events, except as required by law.\n\nPlease see www.TAVALISSE.com for full Prescribing Information.\n\nTAVALISSE and TAVLESSE are registered trademarks of Rigel Pharmaceuticals, Inc.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Investor Contact for <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.:\n\n<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.\n\nSamira Sakhia\n\nPresident & Chief Executive Officer\n\nT: 514.484.4483\n\nF: 514.481.4116\n\nEmail: [email protected]\n\nWebsite: www.gud-knight.com Arvind Utchanah\n\nChief Financial Officer\n\nT. 598.2626.2344\n\n\n\nEmail: [email protected]\n\nWebsite: www.gud-knight.com\n\nReferences:",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> Enters into Exclusive License and Supply Agreements with Rigel Pharmaceuticals to Commercialize Fostamatinib in Latin America",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
},
{
"symbol": "GUD.TO",
"name": "Knight Therapeutics Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Healthcare",
"match_score": 92.193855,
"sentiment_score": 0.224856,
"highlights": [
{
"highlight": "English French\n\nMONTREAL, May 24, 2022 (GLOBE NEWSWIRE) -- <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>TSX</em>: <em>GUD</em>), a pan-American (ex-USA) specialty pharmaceutical company, today announced that it has entered into exclusive license and supply agreements with Rigel Pharmaceuticals granting Knight the rights to commercialize fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, in Latin America.",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "About Knight\n\n<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.'s shares trade on TSX under the symbol GUD. For more information about <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>., please visit the company's web site at www.gud-knight.com or www.sedar.com.\n\nForward-Looking Statements for Knight\n\nThis document contains forward-looking statements for <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. and its subsidiaries.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared but cautions the reader that these assumptions regarding future events, many of which are beyond the control of <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. and its subsidiaries, may ultimately prove to be incorrect.",
"sentiment": 0.1154,
"highlighted_in": "main_text"
},
{
"highlight": "Factors and risks, which could cause actual results to differ materially from current expectations are discussed in <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.'s Annual Report and in <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.'s Annual Information Form for the year ended December 31, 2021, as filed on www.sedar.com.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>. disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information or future events, except as required by law.\n\nPlease see www.TAVALISSE.com for full Prescribing Information.\n\nTAVALISSE and TAVLESSE are registered trademarks of Rigel Pharmaceuticals, Inc.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Investor Contact for <em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.:\n\n<em>Knight</em> <em>Therapeutics</em> <em>Inc</em>.\n\nSamira Sakhia\n\nPresident & Chief Executive Officer\n\nT: 514.484.4483\n\nF: 514.481.4116\n\nEmail: [email protected]\n\nWebsite: www.gud-knight.com Arvind Utchanah\n\nChief Financial Officer\n\nT. 598.2626.2344\n\n\n\nEmail: [email protected]\n\nWebsite: www.gud-knight.com\n\nReferences:",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Knight</em> <em>Therapeutics</em> Enters into Exclusive License and Supply Agreements with Rigel Pharmaceuticals to Commercialize Fostamatinib in Latin America",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "5de9bb72-0324-4ca9-853c-a5594db59495",
"title": "Savaria déclare son dividende mensuel",
"description": "LAVAL, Québec, 24 mai 2022 (GLOBE NEWSWIRE) -- Corporation Savaria (« Savaria ») (TSX : SIS) un des chefs de file mondiaux de l’industrie de...",
"keywords": "Toronto Stock Exchange:SIS, Savaria Corporation, Dividends",
"snippet": "English French\n\nLAVAL, Québec, 24 mai 2022 (GLOBE NEWSWIRE) -- Corporation Savaria (« Savaria ») (TSX : SIS) un des chefs de file mondiaux de l’industrie d...",
"url": "https://www.globenewswire.com/news-release/2022/05/24/2449244/0/fr/Savaria-d%C3%A9clare-son-dividende-mensuel.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/5c02ceb8-fbee-4869-8fa5-97a7d796a22a?size=1",
"language": "en",
"published_at": "2022-05-24T11:45:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "SIS.TO",
"name": "Savaria Corporation",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 102.38449,
"sentiment_score": 0.02965,
"highlights": [
{
"highlight": "English French\n\nLAVAL, Québec, 24 mai 2022 (GLOBE NEWSWIRE) -- Corporation <em>Savaria</em> (« <em>Savaria</em> ») (<em>TSX</em> : <em>SIS</em>) un des chefs de file mondiaux de l’industrie de l’accessibilité, a déclaré aujourd’hui un dividende de 4,17 cents (0,0417 $) par action ordinaire, conformément à sa politique de dividende mensuel, payable le 10 juin 2022 aux actionnaires inscrits",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "À propos de <em>Savaria</em> <em>Corporation</em>\n\n<em>Savaria</em> <em>Corporation</em> (savaria.com) est un chef de file mondial de l’industrie de l’accessibilité. Elle offre des solutions aux personnes à mobilité réduite afin d’accroître leur confort, leur mobilité et leur liberté. Sa gamme de produits est l’une des plus complètes sur le marché.",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Savaria</em> conçoit, fabrique, distribue et installe des équipements d’accessibilité, tels que des sièges pour escaliers droits et courbes, des plates-formes élévatrices verticales et inclinées et des ascenseurs résidentiels et commerciaux.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Savaria</em> fait aussi la conversion et l’adaptation de véhicules, à des fins personnelles et commerciales. Elle exploite un réseau de vente aux distributeurs à travers le monde et des bureaux de vente directe en Amérique du Nord, en Europe (Royaume-Uni, Pays-Bas, Suisse, Italie, Allemagne, Pologne et République tchèque), en Australie et en Chine.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Savaria</em> emploie approximativement 2 250 personnes mondialement et ses usines sont situées à travers le Canada, aux États-Unis, en Europe et en Chine.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Savaria</em> déclare son dividende mensuel",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "21110baf-3b22-4833-b007-4fbcf2a6ad4b",
"title": "Savaria Declares Monthly Dividend",
"description": "LAVAL, Quebec, May 24, 2022 (GLOBE NEWSWIRE) -- Savaria Corporation (“Savaria”) (TSX: SIS) a global leader in the accessibility industry, declared today...",
"keywords": "Toronto Stock Exchange:SIS, Savaria Corporation, Dividends",
"snippet": "English French\n\nLAVAL, Quebec, May 24, 2022 (GLOBE NEWSWIRE) -- Savaria Corporation (“Savaria”) (TSX: SIS) a global leader in the accessibility industry, de...",
"url": "https://www.globenewswire.com/news-release/2022/05/24/2449244/0/en/Savaria-Declares-Monthly-Dividend.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/7d3b6817-d8e4-451a-818d-0c3320f8d54f?size=1",
"language": "en",
"published_at": "2022-05-24T11:45:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "SIS.TO",
"name": "Savaria Corporation",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 109.1708,
"sentiment_score": 0.28195,
"highlights": [
{
"highlight": "English French\n\nLAVAL, Quebec, May 24, 2022 (GLOBE NEWSWIRE) -- <em>Savaria</em> <em>Corporation</em> (“<em>Savaria</em>”) (<em>TSX</em>: <em>SIS</em>) a global leader in the accessibility industry, declared today a dividend of 4.17 cents ($0.0417) per common share, in accordance with its monthly dividend policy, payable on June 10, 2022, to shareholders of record of the Corporation at the close",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Savaria</em> <em>Corporation</em>\n\n<em>Savaria</em> <em>Corporation</em> (savaria.com) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market.",
"sentiment": 0.7479,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Savaria</em> designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use.",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "In addition, <em>Savaria</em> converts and adapts vehicles for personal and commercial uses. The Corporation operates a sales network of dealers worldwide and direct sales offices in North America, Europe (UK, The Netherlands, Switzerland, Italy, Germany, Poland and Czech Republic), Australia and China.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Savaria</em> employs approximately 2,250 people globally and its plants are located across Canada, the United States, Europe and China.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Savaria</em> Declares Monthly Dividend",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "c4a902f6-3b0a-413b-b2c4-84341bb4f14f",
"title": "Tanzanian Gold (NYSEAMERICAN:TRX) Now Covered by HC Wainwright",
"description": "Read Tanzanian Gold (NYSEAMERICAN:TRX) Now Covered by HC Wainwright at ETF Daily News",
"keywords": "Tanzanian Gold, NYSEAMERICAN:TRX, TRX, Basic Material, Initiated Coverage, HC Wainwright",
"snippet": "Research analysts at HC Wainwright assumed coverage on shares of Tanzanian Gold (NYSEAMERICAN:TRX – Get Rating) (NYSEMKT:TRX) in a report released on Tuesday,...",
"url": "https://www.etfdailynews.com/2022/05/24/tanzanian-gold-nyseamericantrx-now-covered-by-hc-wainwright/",
"image_url": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tanzanian-gold-co-logo.png&w=240&h=240&zc=2",
"language": "en",
"published_at": "2022-05-24T11:34:54.000000Z",
"source": "etfdailynews.com",
"relevance_score": null,
"entities": [
{
"symbol": "TNX.TO",
"name": "Tanzanian Gold Corporation",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Basic Materials",
"match_score": 93.40366,
"sentiment_score": 0.42535,
"highlights": [
{
"highlight": "Research analysts at HC Wainwright assumed coverage on shares of <em>Tanzanian</em> <em>Gold</em> (NYSEAMERICAN:TRX – Get Rating) (NYSEMKT:TRX) in a report released on Tuesday, The Fly reports. The firm set a “buy” rating on the basic materials company’s stock.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Separately, Zacks Investment Research raised <em>Tanzanian</em> <em>Gold</em> from a “hold” rating to a “buy” rating and set a $0.25 target price for the company in a research note on Thursday, April 21st.\n\nGet <em>Tanzanian</em> <em>Gold</em> alerts:\n\nShares of TRX stock opened at $0.32 on Tuesday. <em>Tanzanian</em> <em>Gold</em> has a twelve month low of $0.26 and a twelve month high of $0.60.",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "Virtu Financial LLC purchased a new position in <em>Tanzanian</em> <em>Gold</em> during the first quarter worth about $45,000. Renaissance Technologies LLC grew its position in <em>Tanzanian</em> <em>Gold</em> by 325.1% during the first quarter.",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Finally, Guild Investment Management Inc. grew its position in <em>Tanzanian</em> <em>Gold</em> by 14.3% during the fourth quarter. Guild Investment Management Inc. now owns 400,000 shares of the basic materials company’s stock worth $158,000 after buying an additional 50,000 shares in the last quarter. Institutional investors own 0.97% of the company’s stock.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tanzanian</em> <em>Gold</em> Company Profile (Get Rating)\n\n<em>Tanzanian</em> <em>Gold</em> <em>Corporation</em> engages in the acquisition, financing, exploration and development of mineral property interests in the United Republic of Tanzania. The company primarily explores for gold deposits. It holds interests in the Buckreef gold project located in north-central Tanzania.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "The company was formerly known as Tanzanian Royalty Exploration Corporation and changed its name to <em>Tanzanian</em> <em>Gold</em> <em>Corporation</em> in April 2019.\n\nFurther Reading\n\nWant More Great Investing Ideas?",
"sentiment": 0.7624,
"highlighted_in": "main_text"
},
{
"highlight": "Receive News & Ratings for <em>Tanzanian</em> <em>Gold</em> Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for <em>Tanzanian</em> <em>Gold</em> and related companies with MarketBeat.com's FREE daily email newsletter.",
"sentiment": 0.6166,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tanzanian</em> <em>Gold</em> (NYSEAMERICAN:TRX) Now Covered by HC Wainwright",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "3d30dc39-8b23-4aa4-95ef-cd8a062b38b3",
"title": "Almaden Minerals (NYSE:AAU) Now Covered by StockNews.com",
"description": "Read Almaden Minerals (NYSE:AAU) Now Covered by StockNews.com at ETF Daily News",
"keywords": "Almaden Minerals, NYSE:AAU, AAU, Basic Material, Initiated Coverage, StockNews.com",
"snippet": "StockNews.com initiated coverage on shares of Almaden Minerals (NYSE:AAU – Get Rating) in a research report issued to clients and investors on Tuesday. The br...",
"url": "https://www.etfdailynews.com/2022/05/24/almaden-minerals-nyseaau-now-covered-by-stocknews-com/",
"image_url": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/generic-stocks.jpg&w=240&h=240&zc=2",
"language": "en",
"published_at": "2022-05-24T05:08:50.000000Z",
"source": "etfdailynews.com",
"relevance_score": null,
"entities": [
{
"symbol": "0UH8.L",
"name": "Almaden Minerals Ltd.",
"exchange": "LSE",
"exchange_long": "London Stock Exchange",
"country": "gb",
"type": "equity",
"industry": "Basic Materials",
"match_score": 63.507896,
"sentiment_score": 0.7783,
"highlights": [
{
"highlight": "Get Almaden Minerals alerts:\n\nAbout Almaden Minerals (Get Rating)\n\n<em>Almaden</em> <em>Minerals</em> <em>Ltd</em>., an exploration stage company, engages in the acquisition, exploration, evaluation, and development of mineral properties. It primarily owns a 100% interest in the Ixtaca gold-silver project located in Puebla State, Mexico.",
"sentiment": 0.7783,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAU",
"name": "Almaden Minerals Ltd.",
"exchange": "NYSEAMERICAN",
"exchange_long": "NYSE American",
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 63.495773,
"sentiment_score": 0.7783,
"highlights": [
{
"highlight": "Get Almaden Minerals alerts:\n\nAbout Almaden Minerals (Get Rating)\n\n<em>Almaden</em> <em>Minerals</em> <em>Ltd</em>., an exploration stage company, engages in the acquisition, exploration, evaluation, and development of mineral properties. It primarily owns a 100% interest in the Ixtaca gold-silver project located in Puebla State, Mexico.",
"sentiment": 0.7783,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMM.TO",
"name": "Almaden Minerals Ltd.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Basic Materials",
"match_score": 63.49425,
"sentiment_score": 0.7783,
"highlights": [
{
"highlight": "Get Almaden Minerals alerts:\n\nAbout Almaden Minerals (Get Rating)\n\n<em>Almaden</em> <em>Minerals</em> <em>Ltd</em>., an exploration stage company, engages in the acquisition, exploration, evaluation, and development of mineral properties. It primarily owns a 100% interest in the Ixtaca gold-silver project located in Puebla State, Mexico.",
"sentiment": 0.7783,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAUN.MX",
"name": "Almaden Minerals Ltd.",
"exchange": "BMV",
"exchange_long": "Mexican Stock Exchange",
"country": "mx",
"type": "equity",
"industry": "Basic Materials",
"match_score": 63.53736,
"sentiment_score": 0.7783,
"highlights": [
{
"highlight": "Get Almaden Minerals alerts:\n\nAbout Almaden Minerals (Get Rating)\n\n<em>Almaden</em> <em>Minerals</em> <em>Ltd</em>., an exploration stage company, engages in the acquisition, exploration, evaluation, and development of mineral properties. It primarily owns a 100% interest in the Ixtaca gold-silver project located in Puebla State, Mexico.",
"sentiment": 0.7783,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "70261bb7-442d-49e0-8f48-1494138bc29a",
"title": "Revenue of Heart Valve Devices Market Estimated at US$ 26.3 Mn by 2031, TMR Study",
"description": "Increasing regulatory approvals for new and advanced prosthetic heart valves for the increasing incidence of both congenital and non-congenital heart...",
"keywords": "Transparency Market Research, Heart Valve Devices Market, Market Research, Heart Valve Devices, Mechanical Heart Valve, Biological Heart Valve, Healthcare",
"snippet": "Albany NY, United States, May 24, 2022 (GLOBE NEWSWIRE) -- The heart valve devices market is projected to clip a CAGR of 11.9% for the forecast period from 2022...",
"url": "https://www.globenewswire.com/news-release/2022/05/24/2449222/0/en/Revenue-of-Heart-Valve-Devices-Market-Estimated-at-US-26-3-Mn-by-2031-TMR-Study.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/0a34c683-c29f-445e-b3fb-4ca11b37329c?size=1",
"language": "en",
"published_at": "2022-05-24T11:30:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVCN.TO",
"name": "Neovasc Inc.",
"exchange": "TSX",
"exchange_long": "Toronto Stock Exchange",
"country": "ca",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.523403,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Neovasc</em> <em>Inc</em>.\n\nMicro Interventional Devices\n\nTTK Healthcare\n\n\n\n\n\nMake an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "TSX",
"total_documents": 229,
"sentiment_avg": 0.37320754547290047
}
]
}
Other details
Country
- ca
- 16,965